1. Temporary policy for compounding of certain drugs for hospitalized patients by pharmacy compounders not registered as outsourcing facilities during the COVID-19 public health emergency (revised) Publication: [Silver Spring, MD] : Center for Drug Evaluation and Research, Office of Compliance May 21, 2020 Subject(s): Drug Compounding -- methodsHospitalizationOutsourced ServicesPharmaciesCOVID-19United StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
